Business Description
Phibro Animal Health Corp
NAICS : 311119
SIC : 742
ISIN : US71742Q1067
Share Class Description:
PAHC: Class ATotal Employee Number:
2,475Compare
Compare
Traded in other countries / regions
PAHC.USAPB8.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2014-04-11Description
Phibro Animal Health Corp is a world-wide diversified animal health and mineral nutrition company. It strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. It develop, manufacture and market products for food animals including poultry, beef and dairy cattle, swine, aquaculture and dogs. It has three segments Animal Health, Mineral Nutrition, and Performance Products. Majority of revenue comes from Animal Health segment. Animal health products are anti-bacterials, anticoccidials, nutritional specialty products, and vaccines, and vaccine adjuvants that help improve the animal's health.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 2.05 | |||||
Debt-to-EBITDA | 3.39 | |||||
Interest Coverage | 4.41 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.05 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 29.5 | |||||
3-Year EPS without NRI Growth Rate | 38.6 | |||||
3-Year Book Growth Rate | 10.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 8.98 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.55 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.21 | |||||
9-Day RSI | 52.93 | |||||
14-Day RSI | 55.43 | |||||
3-1 Month Momentum % | 7.97 | |||||
6-1 Month Momentum % | -28.44 | |||||
12-1 Month Momentum % | -13.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.96 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.26 | |||||
Days Inventory | 182.08 | |||||
Days Sales Outstanding | 53.96 | |||||
Days Payable | 47.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.27 | |||||
Dividend Payout Ratio | 0.15 | |||||
Forward Dividend Yield % | 1.27 | |||||
5-Year Yield-on-Cost % | 1.27 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -3.71 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.76 | |||||
Operating Margin % | 12.81 | |||||
Net Margin % | 6.57 | |||||
EBITDA Margin % | 15.34 | |||||
FCF Margin % | 0.65 | |||||
OCF Margin % | 4.54 | |||||
ROE % | 29.73 | |||||
ROA % | 7.02 | |||||
ROIC % | 12.15 | |||||
3-Year ROIIC % | 22.07 | |||||
ROC (Joel Greenblatt) % | 19.45 | |||||
ROCE % | 16.04 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.29 | |||||
Forward PE Ratio | 10.66 | |||||
PE Ratio without NRI | 11.62 | |||||
Shiller PE Ratio | 24.85 | |||||
Price-to-Owner-Earnings | 58.02 | |||||
PEG Ratio | 0.98 | |||||
PS Ratio | 1.01 | |||||
PB Ratio | 3.93 | |||||
Price-to-Tangible-Book | 5.12 | |||||
Price-to-Free-Cash-Flow | 154.81 | |||||
Price-to-Operating-Cash-Flow | 22.16 | |||||
EV-to-EBIT | 12.25 | |||||
EV-to-Forward-EBIT | 18.39 | |||||
EV-to-EBITDA | 9.54 | |||||
EV-to-Forward-EBITDA | 10.28 | |||||
EV-to-Revenue | 1.46 | |||||
EV-to-Forward-Revenue | 1.05 | |||||
EV-to-FCF | 225.18 | |||||
Price-to-GF-Value | 1.19 | |||||
Price-to-Projected-FCF | 3.28 | |||||
Price-to-Median-PS-Value | 0.91 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.9 | |||||
Price-to-Graham-Number | 1.63 | |||||
Earnings Yield (Greenblatt) % | 8.16 | |||||
FCF Yield % | 0.65 | |||||
Forward Rate of Return (Yacktman) % | 13.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PAHC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Phibro Animal Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,518.093 | ||
| EPS (TTM) ($) | 2.44 | ||
| Beta | 0.2061 | ||
| 3-Year Sharpe Ratio | 0.81 | ||
| 3-Year Sortino Ratio | 1.43 | ||
| Volatility % | 62.51 | ||
| 14-Day RSI | 55.43 | ||
| 14-Day ATR ($) | 1.580077 | ||
| 20-Day SMA ($) | 36.2025 | ||
| 12-1 Month Momentum % | -13.04 | ||
| 52-Week Range ($) | 28.25 - 60.08 | ||
| Shares Outstanding (Mil) | 40.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Phibro Animal Health Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Phibro Animal Health Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2027-02-05 09:00 | In 150 days | ||
| Second quarter earnings results for 2027 | 2027-02-05 | In 149 days | ||
| First quarter earnings conference call for 2027 | 2026-11-06 09:00 | In 59 days | ||
| First quarter earnings results for 2027 | 2026-11-05 | In 57 days | ||
| General meeting for 2026 | 2026-11-04 09:00 | In 57 days | ||
| USD 0.120000 Cash Dividend | 2026-09-02 | 38.37 (+1.59%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-27 09:00 | 36.09 (-1.07%) | ||
| Annual report for 2026 | 2026-08-26 | 35.93 (+0.62%) | ||
| Fourth quarter earnings results for 2026 | 2026-08-26 | 35.93 (+0.62%) | ||
| USD 0.120000 Cash Dividend | 2026-06-03 | 28.52 (-4.39%) |
Show
Entries
Phibro Animal Health Corp Frequently Asked Questions
What is Phibro Animal Health Corp(PAHC)'s stock price today?
The current price of PAHC is $37.31. The 52 week high of PAHC is $60.08 and 52 week low is $28.25.
When is next earnings date of Phibro Animal Health Corp(PAHC)?
The next earnings date of Phibro Animal Health Corp(PAHC) is 2026-11-05 Est..
Does Phibro Animal Health Corp(PAHC) pay dividends? If so, how much?
The Dividend Yield %  of Phibro Animal Health Corp(PAHC) is 1.27% (As of Today), Highest Dividend Payout Ratio of Phibro Animal Health Corp(PAHC) was 0.44. The lowest was 0.15. And the median was 0.33. The  Forward Dividend Yield % of Phibro Animal Health Corp(PAHC) is 1.27%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Phibro Animal Health Corp
Phibro Animal Health Corp (PAHC) Shares Surge 3.9% -- What GF Score of 71 Tells Investors
6 days ago
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers